Form D · Pharmaceuticals

Biocure Technology Inc.

Vancouver, A1 · CIK 0001831492

Offering snapshot reported Nov 12, 2020 · SEC filing

Reported sold
$10.7K
Offering amount: $26.6K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 14, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 12, 2020Initial$10,656No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-380257
US dollars have been converted from Canadian dollars using the 0.7611 Bank of Canada daily exchange rate on 10-14-20. Total Remaining to be Sold represents the aggregate exercise price of warrants sold in the offering in the United States.
Units, each comprised of one common share and one common share purchase warrant, with each warrant having a CAD$0.21 exercise price and a 2-year term.

Source: Form D, filed Nov 12, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Hans Frykman Director
Danny Joh Director
Sang Goo (Collin) Kim Director
Sang Mok Lee Director, Executive
Konstantin Konstantin Lichtenwald Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
300 1055 West Hastings Street
Vancouver, A1, V6E 2E9